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Purpose: To identify the causative gene for autosomal recessive Leber congenital amaurosis (LCA) in a Chinese family.
Methods: One Chinese LCA family was identified and an ophthalmologic examination was performed. The genetic
defects were analyzed simultaneously by a genome-wide linkage scan with 382 polymorphic microsatellite markers, as
well as by comprehensive mutational screening of 15 genes known to associate with LCA on the genomic DNA of this
family.
Results: Suggestive linkages were found in 13 chromosomal regions, of which only one harbored a known causative gene,
crumbs homolog 1 (CRB1), on chromosome 1. Sanger sequencing of CRB1 identified two novel heterozygous mutations,
c.3221T>C (p.L1074S) and c.2677–2A>C. In addition, a novel missense heterozygous mutation, c.938C>A (p.A313D),
in spermatogenesis associated 7 (SPATA7), was detected in the proband after screening of the other 14 LCA causative
genes. All three affected individuals of the family had compound heterozygous CRB1 mutations, and one of the three (the
proband) had an additional mutation in SPATA7. The unaffected mother had the heterozygous c.3221T>C mutation in
CRB1 and the heterozygous c.938C>A mutation in SPATA7. The unaffected father could not be tested, but presumably
had the heterozygous c.2677–2A>C mutation in CRB1. The proband, with triallelic mutations in CRB1 and SPATA7, had
a phenotype similar to other two affected brothers, suggesting the additional mutant allele in SPATA7 might not contribute
to the disease. Similarly, the mother, with digenic mutations in CRB1 and SPATA7, had normal vision and fundi, suggesting
the digenic mutations in these two genes might not cause disease.
Conclusions: Digenic and triallelic mutations of CRB1 and SPATA7 were detected in a family with LCA. Our results
imply that CRB1 and SPATA7 may not interact with each other directly. This emphasizes that care should be taken in
invoking a mutation–disease association for digenic and triallelic mutations.
Leber congenital amaurosis (LCA, OMIM 204000) is an
extreme and highly heterogeneous form of retinal dystrophy,
characterized  by  severe  visual  loss  at  or  near  birth,
Franceschetti's  oculodigital  sign,  searching  or  roving
nystagmus, and pigmentary retinopathy [1,2]. Visual acuity is
rarely  better  than  20/400  [3],  and  fundus  changes  are
extremely  variable,  ranging  from  normal  appearance  to
obvious  pigmentary  retinopathy  similar  to  retinitis
pigmentosa. Electroretinogram (ERG) recordings are usually
flat lines or severely abnormal [2]. The prevalence of LCA is
around  one  to  two  per  80,000  live  births,  accounting  for
approximately 20% of cases of inherited blindness among
children in institutes for the blind and more than 5% of all
congenital retinopathies. At present, 18 LCA loci have been
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mapped, in which 17 causative genes have been identified:
guanylate  cyclase  2D  (GUCY2D)  [4],  crumbs  homolog  1
(CRB1)  [5],  retinal  pigment  epithelium-specific  protein
65 kDa (RPE65) [6], retinitis pigmentosa GTPase regulator
interacting  protein  1  (RPGRIP1)  [7],  aryl  hydrocarbon
receptor  interacting  protein-like  1  (AIPL1)  [8],  Leber
congenital  amaurosis  5  (LCA5)  [9],  cone-rod  homeobox
(CRX)  [10],  lecithin  retinol  acyltransferase  (LRAT)  [11],
tubby like Protein 1(TULP1) [12], retinol dehydrogenase 12
(RDH12) [13], centrosomal Protein 290 kDa (CEP290) [14],
retinal degeneration 3 (RD3) [15], spermatogenesis associated
7  (SPATA7)  [16],  (inosine  5′-monophosphate  [IMP])
dehydrogenase 1 (IMPDH1) [17], orthodenticle homeobox 2
(OTX2)  [18],  IQ  motif  containing  B1  (IQCB1)  [19],  and
calcium binding protein 4 (CABP4) [20]. Although LCA was
mostly thought to be transmitted as a recessive and dominant
trait  [2],  some  LCA  cases  show  a  triallelic  or  digenic
inheritance [21,22].
Here, we report an autosomal recessive LCA family with
three affected members from Guangdong Province, China.
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3326After  a  genome-wide  linkage  scan  and  comprehensive
mutational screening, two novel mutations in CRB1 and one
novel  mutation  in  SPATA7  were  identified  in  the  family,
demonstrating digenic mutations in an unaffected individual,
triallelic mutations in one affected individual, and compound
heterozygous mutations in two affected individuals with a
phenotype indistinguishable from their sibling with triallelic
mutations.
METHODS
Leber congenital amaurosis family: Family 83002 with LCA
was collected from the Pediatric and Genetics Clinic of the
Zhongshan  Ophthalmic  Center,  Sun  Yat-sen  University,
Guangzhou, China. They were of the Chinese Han ethnicity
and lived in Yangjiang of Guangdong Province, China. The
pedigree  and  clinical  phenotype  suggested  autosomal
recessive inheritance of the disease in this family. Written
informed consent conforming to the tenets of the Declaration
of Helsinki and following the Guidance of Sample Collection
of Human Genetic Diseases (863-Plan) by the Ministry of
Public Health of China was obtained from the participating
individuals or their guardians before the study. Three affected
siblings and the unaffected mother of the family participated
in  this  linkage  study.  Genomic  DNA  was  prepared  from
leukocytes of peripheral venous blood.
Genotype  analysis  and  linkage  analysis:  A  genome-wide
linkage scan was performed with 382 highly polymorphic
fluorescent markers from the ABI PRISM Linkage Mapping
Set MD-10 (Applied Biosystems, Foster City, CA). Multiplex
PCR  was  performed  in  a  GeneAmp  PCR  System  9700
thermocycler (Applied Biosystems). Briefly, each reaction
was performed in a 5 μl mixture containing 20 ng genomic
DNA. Initial denaturation was performed for 5 min at 95 °C,
followed by 10 cycles of 15 s at 95 °C, 15 s at 55 °C, and 30
s at 72 °C, and then 20 cycles of 15 s at 89 °C, 15 s at 55 °C,
and 30 s at 72 °C. The final extension was performed for 10
min at 72 °C. PCR products for a subset of markers from each
subject were pooled and mixed with HD-400 size standards
(Applied Biosystems). Different alleles were separated using
an ABI 3130 DNA analyzer (Applied Biosystems) and then
assigned  using  GeneMapper  (version  4.0;  Applied
Biosystems).  Two-point  linkage  analyses  were  performed
using  the  MLINK  from  the  LINKAGE  program  package
[23,24].  Maximum  logarithm  of  odds  (LOD)  scores  were
calculated  using  ILINK.  Autosomal  recessive  LCA  was
analyzed  as  a  fully  penetrant  trait  with  an  affected  allele
frequency of 0.0001. The marker order and distances between
the markers were obtained from the Genethon database.
LCA candidate gene screening: All candidate gene in regions
with  a  suggestive  linkage  were  analyzed  by  Sanger
sequencing. Simultaneously, 15 genes known to associate
with LCA were analyzed by Sanger sequencing, as previously
described   [25],     including    GUCY2D,    CRB1,    RPE65,
RPGRIP1,  AIPL1,  LCA5,   CRX,  LRAT,  TULP1,  RDH12, 
CEP290,     RD3,      SPATA7,      IMPDH1,     and     OTX2.    
Briefly, PCR amplifications were performed in 10 μl reactions
containing  40  ng  genomic  DNA.  Touchdown  PCR
amplification consisted of a denaturizing step at 96 °C for 5
min, followed by decreasing the annealing temperature from
an initial 64 °C by 0.5 °C every second cycle for 15 cycles, an
annealing temperature of 57 °C for 21 cycles, and incubation
at 72 °C for 10 min. Sequencing results were assembled using
an  ABI  PRISM  3130  automated  sequencer  (Applied
Biosystems) and analyzed with Seqman software (DNAStar
Lasergene  8,  Madison,  WI)  and  a  mutation  surveyor
(SoftGenetics, State College, PA). A missense mutation was
predicted  to  be  damaging  by  the  position-specific
independent-counts algorithm of Polyphen [26], by a Sorting
Intolerant From Tolerant (SIFT) score (which distinguishes
tolerated variants from those that are not tolerated) equal to or
less than 0.05, and by being absent in 192 ethnically matched
control chromosomes. The splicing changes were predicted
by Automated Splice Site Analyses.
RESULTS
Mutation  detection:  LOD  scores  greater  than  1.0  were
obtained in 13 chromosomal regions (data not shown), of
which  only  one  harbored  a  gene  known  to  cause  LCA,
TABLE 1. TWO-POINT LOD SCORES OF FAMILY 83002 FOR MAKERS ON 1P.
  Position Lod score at theta=
Markers cM* Mb# 0 0.01 0.05 0.1 0.2 0.3 0.4
D1S218 196.5 174.5 -inf −0.81 −0.18 0.02 0.12 0.09 0.03
D1S238 206.7 188.1 1 0.98 0.87 0.74 0.48 0.24 0.06
CRB1   197.2 1.2 1.18 1.07 0.93 0.64 0.34 0.1
D1S413 216.5 198.6 0.49 0.47 0.43 0.37 0.24 0.12 0.03
D1S249 225.1 205.7 0.49 0.47 0.43 0.37 0.24 0.12 0.03
D1S425 235.3 212.1 0.49 0.47 0.43 0.37 0.24 0.12 0.03
D1S213 246.2 223.8 -inf −0.97 −0.34 −0.12 0.02 0.03 0.01
          • Genethon • # Homo genome (Build 37.2) Chr1 Primary_Assembly.
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3327CRB1 on chromosome 1, which gave a LOD score of 1.18,
near the theoretical maximum for this family (Table 1).
Sanger  sequencing  of  CRB1  identified  two  novel
heterozygous mutations, c.3221T>C (p.L1074S) and c.2677–
2A>C, in the proband (II:1). Simultaneous comprehensive
mutation screening in the remaining 14 of the 15 known LCA
genes  detected  a  single  additional  novel  missense
heterozygous mutation, c.938C>A (p.A313D), in SPATA7 in
the  proband  (Figure  1).  No  mutation  was  detected  in
GUCY2D, RPE65, RPGRIP1, AIPL1, LCA5, CRX, LRAT,
TULP1, RDH12, CEP290, RD3, IMPDH1, or OTX2.
The other two affected patients (II:2 and II:3) in this
family  had  only  the  two  compound  heterozygous  CRB1
mutations without the c.938C>A mutation in SPATA7 (Figure
1). The unaffected mother had the heterozygous c.3221T>C
mutation in CRB1 and the heterozygous c.938C>A mutation
in SPATA7. By implication, the unaffected father presumably
had the heterozygous c.2677–2A>C mutation in CRB1.
None of the three mutations were detected in the 192
chromosomes of the normal controls. Of the three mutations,
the c.2677–2A>C mutation in CRB1 was predicted to abolish
the splicing site, altering the invariant 2A residue in intron 7.
The other two mutations, c.3221T>C (p.L1074S) in CRB1
and c.938C>A (p.A313D) in SPATA7, were predicted to be
damaged by SIFT or probably damaging by Polyphen (Table
2).  The  L1074  in  CRB1  and  the  A313  in  SPATA7  were
relatively well conserved residues (Figure 2).
Clinical  phenotype:  Clinical  information  of  the  family
members is listed in Table 3. All three patients from the family
were found to have poor vision and nystagmus in the first few
months after birth. The ERGs of rod and cone responses were
unrecordable. The patients in this family first visited our clinic
when  they  were  preschool  children.  Their  visual  acuity,
fundus changes, and ERG recordings were similar during
follow-up visits for over ten years. For patient II:1, the right
eye’s visual acuity was 0.04 and the left eye’s was 0.05. For
patient II:2, the right eye’s visual acuity was 0.02 and the left
Figure  1.  Pedigree  and  haplotypes:
sequence changes of family 83002. (The
DNA sample for I:1 was not available.)
A: Haplotypes of the CRB1 region of
family  83002  showing  the  CRB1  c.
3221T>C and c.2677–2A>C mutations
and surrounding microsatellite markers
included in Table 1. The risk haplotype
is  shown  in  black  and  green.  B,  C:
Electropherograms  demonstrate
sequences  in  the  regions  with  the
CRB1  c.3221T>C  and  c.2677–2A>C
mutations in individuals I:2, II:1, II:2, II:
3,  and  a  normal  control.  D:
Electropherograms show the c.938C>A
mutation in SPATA7 of individuals I:2
and II:1.
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3328eye was finger counting. For patient II:3, the right eye’s visual
acuity was 0.06 and the left eye’s was 0.03. All three patients
had  hyperopia  correlated  with  short  axial  length,  which
suggested microphthalmia (Table 3). The corneal diameters
and corneal curvatures of the three patients were similar and
within normal range (Figure 3). The fundus changes in all
three patients were similar, including the waxy paleness of
optic disc, artery attenuation, generalized carpetlike retinal
degeneration, macular atrophy, nummular pigmentation at the
posterior pole, and irregular pigmentation and white dots at
the  midperipheral  region  (Figure  4).  Optical  coherence
tomography  showed  thinning  of  the  retina  and  loss  of
photoreceptor layers (Figure 5). Overall, the proband (patient
II:1) with triallelic mutations in CRB1 and SPATA7 had a
phenotype similar to the other two affected brothers’, as well
as better visual acuity than that of most LCA patients with
other CRB1 mutations or with mutations in other LCA genes
[25], suggesting that the additional mutant allele in SPATA7
might not contribute to the disease. The mother with digenic
mutations in CRB1 and SPATA7 had normal vision, a normal
fundus appearance, and a normal visual field (data not shown),
suggesting that the digenic mutations in these two genes might
not be causative.
TABLE 2. MUTATIONS IN THE 15 GENES DETECTED IN 83002 FAMILY WITH LCA AND IN 192 CHROMOSOMES OF CONTROLS.
Gene
Nucleotide
change
Amino acid
change Conservation
Computational prediction
Remark
Occurance
in controls Report         Blosum62* PolyPhen or
Splice Site
SIFT      
CRB1 c.3221T>C L1074S Yes 6 probably
damaging
damaging Pathogenic 0/192 This study
  c.2677–2A>C N/A N/A N/A splicing site
abolished
N/A Pathogenic 0/192 This study
SPATA7 c.938C>A A313D Yes 6 probably
damaging
damaging Pathogenic 0/192 This study
         • Difference between the scores. Except for mutations in CRB1 and SPATA1, no other changes were detected in 13 other LCA
         genes, including GUCY2D, RPE65, RPGRIP1, AIPL1, LCA5, CRX, LRAT, TULP1, RDH12, CEP290, RD3, IMPDH1 and
         OTX2.
Figure 2. Protein sequence alignment.
A: CRB1 L1047 amino acid(red) in ten
species  ranging  from  humans  to
zebrafish.  L1047  is  conserved  in  all
species from Homo sapiens to Danio
rerio as ascertained by a bioinformatic
search  of  NCBI-Blast  by  means  of
human  CRB1  DNA  and  protein  and
MegAlign  (DNASTAR  Lasergene,
Madison, WI). And this may indicate
functional or structural significance in
L1047.  B:  SPATA7  A313  amino
acid(red)  in  ten  species  ranging  from
humans  to  mice.  A313  is  relatively
conserved among mammal.
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3329DISCUSSION
Digenic and triallelic mutations have been identified as causes
of  hereditary  retinal  degeneration  [21,27-31].  LCA  is  the
earliest-occurring  and  most  severe  inherited  retinal
degeneration,  and  is  mostly  inherited  as  an  autosomal
recessive trait [2]. Mutations in at least 17 genes have been
identified  as  being  responsible  for  LCA  (RetNet).  It  was
expected  that  digenic  and  triallelic  mutations  would  be
detected in patients with LCA, and we did identify digenic and
triallelic mutations in our previous study [25]. It has been
suggested  in  previous  studies  that  affected  members  in
families that carry a third allele in a second gene have more
severe  phenotypes  than  other  affected  members  [21,32].
However,  further  studies  are  expected  to  reveal  whether
Figure 3. Sagittal curvature of the cornea. Only the right eye of the
four members of the family are shown, since the sagittal curvatures
of both eyes in each individual were similar. The number of color
scale presents the degree of the curvature of cornea. The corneal
diameters and corneal curvatures of the three patients(II:1, II:2 and
II:3) were similar with unaffected mother (I:2) and within normal
range.
digenic  mutations  are  causative  in  general,  and  whether
triallelic mutations usually cause a severe phenotype.
Here,  we  identified  digenic  mutations  in  CRB1  and
SPATA7 in a healthy mother and triallelic mutations in a
proband with LCA after comprehensive genetic study of a
Chinese family with LCA. The fundus pictures of the three
patients  showed  typical  features  of  CRB1-related  LCA:
nummular pigmentation and macular atrophy. The proband
with  triallelic  mutations  in  CRB1  and  SPATA7  had  a
Figure 4. Fundus photos of the four members of the family. The
mother  (I:2),  with  digenic  mutations,  had  a  normal  fundus
appearance. All three patients (II:1, II:2, and II:3) from the family
had similar fundus changes, including waxy, pale optic discs, artery
attenuation,  generalized  carpetlike  retinal  degeneration,  macular
atrophy, nummular pigmentation at the posterior pole, and irregular
pigmentation and white dots in the midperipheral region. The fundus
changes in the proband (II:1) with triallelic mutations in CRB1 and
SPATA7 were similar to the those of the other two patients (II:2 and
II:3) with compound heterozygous CRB1 mutations.
TABLE 3. CLINICAL INFORMATION OF THE INDIVIDUALS IN THE 83002 FAMILY.
ID
Variations
 Age
(year)
First
symptom Age at onset
Axial length
(right/left, mm)
Visual acuity
(right/left eye)
ERG rod and
cone responses   CRB1 SPATA7            
I:2 c.3221T>C c.938C>A 44 No No 21.26/21.23 1.0; 1.0 Normal
II:1 c.3221T>C; c.938C>A 22 PV, NYS* FFMAB* 19.52/19.53 0.04; 0.05 Undetectable
  c.2677–2A>C              
II:2 c.3221T>C; No 20 PV, NYS FFMAB 19.31/19.95 0.02; FC Undetectable
  c.2677–2A>C              
II:3 c.3221T>C; No 18 PV, NYS FFMAB 19.53/19.93 0.06; 0.03 Undetectable
  c.2677–2A>C              
         *Note: ERG: FlDVK ERG. The undetectable records indicated both cone and rod cell degenerated in three patients. PV=poor
         vision (decreased visual acuity); NYS=nystagmus; FFMAB=first few months after birth.
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3330phenotype  similar  to  the  other  two  affected  brothers,
suggesting that the additional mutant allele in SPATA7 might
not  contribute  to  the  disease.  The  mother  with  digenic
mutations in CRB1 and SPATA7 had a normal ocular fundus,
suggesting that digenic mutations in these two genes might
not be causative. This suggests that digenic mutations may not
always  result  in  clinical  consequences,  even  if  they  are
pathogenic mutations, and that they may, on their own, cause
disease  in  the  context  of  a  homozygous  or  compound
heterozygous status. Triallelic mutations may not necessarily
cause  a  severe  phenotype,  even  they  can  cause  the  same
disease  by  themselves.  Our  results  imply  that  CRB1  and
SPATA7 might not interact with each other directly.
Digenic or triallelic mutations are difficult to detect if
these  genes  are  analyzed  independently.  However,  such
mutations will probably be seen more frequently, given the
widespread  application  of  genotyping  microarrays,  next-
generation  sequencing,  and  exome  sequencing.
Cosegregation analyses based on family members will still be
an important tool in validating the clinical significance of
digenic or triallelic mutations. Great care should be taken in
making mutation-disease associations between digenic and
triallelic mutations before there is firm phenotypic evidence
to  support  such  associations,  especially  in  clinical  gene
diagnoses.
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